Remington Ammunition is launching three new rifle cartridges loaded to subsonic muzzle velocities in 2026. The new Boat-tail ...
Ever wonder exactly how twist rate affects projectiles and bullet selection? Dive into this important component of ballistics ...
When introduced, the .338 Win. Mag. offered hunters .375-type performance from a standard long action. These days, there are better options.
Opinion
The Avid Outdoorsman on MSNOpinion
The cartridges that are accurate, affordable, and somehow still ignored
A lot of shooters say they want three things from a cartridge: it needs to be accurate enough to... The post The cartridges that are accurate, affordable, and somehow still ignored appeared first on ...
The 2026 NFL Scouting Combine gets underway this week—the next major step toward the draft on April 23-25 in Pittsburgh. As players are put through their paces in Indianapolis, it will inevitably ...
motorsport.com on MSN
Long-run shock in Australia: George Russell and Mercedes tear the competition apart
While Ferrari and McLaren topped the times in Friday practice, it’s Mercedes that could be the team to beat come Sunday, here’s why ...
Olga Liashchuk sits in first place overall following three incredible events on day one of the 2026 Arnold Strongwoman Classic.
Fiscal 2026 guidance includes $20 million to $30 million in capital investment to optimize the Torrington facility for a ...
Travis Gettys is a senior editor for Raw Story based in northern Kentucky. He previously worked as a web editor for WLWT-TV and a contributing writer for the Kentucky Enquirer, and he also wrote for ...
I drove the 2026 Subaru Uncharted GT through California canyons, a monsoon-like storm, and an off-road course. Here's why this Toyota-based EV feels more authentically Subaru—and whether it's worth ...
Giving Bayer's oral Factor XIa inhibitor asundexian to people who have suffered an ischaemic stroke can reduce the risk of them having another by around a quarter. That is the conclusion of the ...
Roche has shared the numbers behind its phase 3 win in primary progressive multiple sclerosis (PPMS), linking its BTK inhibitor to a 12% reduction in the risk of disability progression compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results